Fritextsökning
Innehållstyper
-
SP vill göra Astra Zenecas säkerhetsenhet till institut
Statens tekniska forskningsinstitut har på uppdrag av Vinnova tagit Ernst and Youngs rapport vidare. Nu vill de göra Astra Zenecas säkerhetsenhet till ett nytt SP-institut.
-
Tre nya toppar till Episurf
Medtech-bolaget stärker ledningsgruppen med tre nya chefer.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Immunicum-teknik i lyckad preklinisk studie
Resultaten publiceras i en vetenskaplig tidskrift.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Google ska hjälpa forskarna med Big Data
It-jätten fortsätter satsa på hälsa och medicinsk forskning med molntjänsten Google Genomics.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Fabrik räddad i sista minuten
För några år sedan var det på håret att den anrika vaccintillverkningen i Solna skulle packas ihop och flyttas utomlands. Men tack vare en övertalningskampanj o...
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Stormöte lockar svenskar
Nu pågår Arab Health Exhibition & Congress – en av världens största hälso- och sjukvårdsmässor. På plats finns många svenska företag, både som utställare och som storsponsorer.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
49 miljoner till dengueforskning
Umeå universitet får ett rekordstort EU-anslag. Pengarna innebär att lärosätet nu kan profilera sig inom forskning om klimatförändringar och hälsa.
-
Så ska läkemedelsplattformen hjälpa forskarna
Om några veckor öppnar Scilifelabs Drug Discovery and Development-plattform. Här ska forskarna i akademin få hjälp att ta fram substanser som kan utvecklas till...
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
BREAKING